Controversial Hydroxycut Suits Have Already Been Entered
On May 1, 2009, there was a recall of fourteen Hydroxycut diet-aid products coming from a number of reports that folks using the products were developing heavy liver problems and other health worries. Less than a week later, on May four, the 1st Hydroxycut class action court action was filed against the company that manufactures the products, Iovate Medical Sciences. The Hydroxycut Lawyer alleges company negligence in informing the public about potential perils of the products. Naturally, it’s too soon to understand the suit is going to turn out, but if the company had information which it did not reveal to consumers, it should definitely be held accountable.
A class action legal action is filed by a group of people, all of whom have similar claims against a certain company. Filing a class action is just as effective, and a lot less dear, than filing an individual suit. As a rule, filing a class action court action will not cost anything unless there is a settlement. At that point, the lawyer who handled the suit will take his costs from the compensation that was awarded and then share the leftover funds to the accusers in the case. Since this is the case, you’ll be able to file a Hydroxycut class action suit without paying a penny out of your own pocket, which is one of the reasons that class action lawsuits have become so popular.
The first class action lawsuit against Iovate was filed in Canada where the company is located and represents all Canadian voters who sustained health problems due to Hydroxycut products. The FDA recall occurred in the US where 23 cases of liver disorders and other health issues had been reported. Health Canada did not receive any reports of liver damage due to the diet products, but they did receive seventeen reports concerning folks who sustained respiratory, neurological, cardiovascular, and stomach problems as a result of Canadians using the products.
The Hydroxycut Settlement Suit alleges the company sold the company sold the general public of the health risks that they could exposing patrons to. The complaint states that the company failed to publish the data on the product labels saying that users could run the risk of liver and kidney damage as well as stomach, heart, respiration, and neurological problems. The suit goes on to claim this was a blatant omission on the part of the company which deliberately misled consumers concerning the protection of the products.
